The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame is an established NIH-funded program, which trains graduate students in a multidisciplinary environment that provides them with significant training at the interface of chemistry and biology-related disciplines. The goal of the CBBI Program is to produce PhD scientists who have in-depth training in the student's core discipline, cross-discipline training to work effectively at the interface, and enhanced interdisciplinary communication skills. The CBBI Program has been very successful and has established an outstanding training environment for our predoctoral trainees. Since 2007 we have trained 55 students, 33 of whom have completed PhD degrees in an average of 5.19 years, including 8 underrepresented minorities (URMs), 6 of whom have already received PhD degrees. Our 55 trainees have 207 publications, of which 94 are first-author publications. This represents 3.76 publications per trainee and 1.71 first-author publications per trainee. The 8 URMs have produced 37 publications, of which 17 are first-author publications; this represents 4.63 publications per URM and 2.13 first-author publications per URM. During the past 9 years, our attrition rate has been extremely low, with only 3 of 55 trainees (5.5%) who did not complete a PhD degree. Not a single trainee has left the program without a PhD degree in the past 5 years, the current cycle of the training program. The characteristics of the CBBI Program include: a large applicant pool of highly qualified candidates, a strong record of collaborative and multidisciplinary research, a diverse and strong group of experienced, productive, and federally-funded investigators available to serve as research mentors, an extended cross-disciplinary research internship outside the mentor's laboratory, training supplementation with multidisciplinary seminars, trainee meetings, an annual symposium, experienced and effective program administration, mechanisms for continuous evaluation and improvement of the training program, professional development and career placement, excellent research facilities, and strong institutional commitment. We propose to continue to train PhD scientists with the skills and expertise to solve challenging biomedical problems, regardless of discipline. The University of Notre Dame enthusiastically supports this training program, and will continue to provide a generous fellowship match to the CBBI Program and additional resources, including the cost of the research internship for all trainees, upon renewal of funding by the NIH.

Public Health Relevance

Cutting-edge biomedical research is highly multidisciplinary, requiring contributions from a diverse group of collaborators. The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame has met this need for cross-disciplinary training and produced researchers with a synergistic combination of scientific skills and expertise, broad knowledge across diverse scientific disciplines, and excellent communication skills. Our goal is to continue to train PhD scientists with the skills and expertise to solve challenging biomedical problems, regardless of discipline.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM075762-14
Application #
9961605
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Fabian, Miles
Project Start
2007-07-01
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
14
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Notre Dame
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
824910376
City
Notre Dame
State
IN
Country
United States
Zip Code
46556
Byun, Byungjin; Mahasenan, Kiran V; Dik, David A et al. (2018) Mechanism of the Escherichia coli MltE lytic transglycosylase, the cell-wall-penetrating enzyme for Type VI secretion system assembly. Sci Rep 8:4110
Del Vecchio, Kathryn; Frick, Cary T; Gc, Jeevan B et al. (2018) A cationic, C-terminal patch and structural rearrangements in Ebola virus matrix VP40 protein control its interactions with phosphatidylserine. J Biol Chem 293:3335-3349
Kane, Trevor L; Carothers, Katelyn E; Lee, Shaun W (2018) Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics. Curr Drug Targets 19:111-127
Dik, David A; Fisher, Jed F; Mobashery, Shahriar (2018) Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance. Chem Rev 118:5952-5984
Dodge, Greg J; Ronnow, Danialle; Taylor, Richard E et al. (2018) Molecular Basis for Olefin Rearrangement in the Gephyronic Acid Polyketide Synthase. ACS Chem Biol 13:2699-2707
Frederick, Thomas E; Peng, Jeffrey W (2018) A gratuitous ?-Lactamase inducer uncovers hidden active site dynamics of the Staphylococcus aureus BlaR1 sensor domain. PLoS One 13:e0197241
Rosales, Anthony R; Quinn, Taylor R; Wahlers, Jessica et al. (2018) Application of Q2MM to predictions in stereoselective synthesis. Chem Commun (Camb) 54:8294-8311
Lee, Mijoon; Batuecas, MarĂ­a T; Tomoshige, Shusuke et al. (2018) Exolytic and endolytic turnover of peptidoglycan by lytic transglycosylase Slt of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 115:4393-4398
Bouchard, Jill J; Xia, Junchao; Case, David A et al. (2018) Enhanced Sampling of Interdomain Motion Using Map-Restrained Langevin Dynamics and NMR: Application to Pin1. J Mol Biol 430:2164-2180
Tomoshige, Shusuke; Dik, David A; Akabane-Nakata, Masaaki et al. (2018) Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the ?-Lactam Antibiotics. ACS Infect Dis 4:860-867

Showing the most recent 10 out of 191 publications